Skip to main content.
Polar NanoPharma
Startup
-
Location
Hall 8.0 – 4YFN & Partner District Stand 8.0B10
Information
Polar NanoPharma is a biotechnology start-up developing advanced nanoparticle drug delivery systems for oncology. Our proprietary polycarbamate–polyurea (PCPU) platform enables precise encapsulation of small molecules and biologics, improving solubility, pharmacokinetics, and controlled tumor release while reducing systemic toxicity. Our pipeline targets high-unmet-need cancers, including triple-negative breast cancer, non-small-cell lung cancer, and preventive immunotherapy approaches for Lynch syndrome in collaboration with Hospital Clínic. Through strategic partnerships and translational development, Polar NanoPharma transforms advanced polymer science into safer, more effective cancer therapies with global clinical and commercial potential.
Key Information
-
Pre-Seed
Growth Stage
-
CountrySpain
-
Founding Year2024